What is your approach to patients with locally recurrent prostate cancer following cryotherapy or HIFU?   

With biopsy-proven, negative systemic restaging disease, what dose and fractionation is appropriate if treating with IMRT? Should ADT generally be included when treating with radiation in this situation?  



Answer from: Radiation Oncologist at Community Practice